Global Cell and Gene Therapy CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 21 Sep 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Cell and Gene Therapy CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Cell and Gene Therapy CDMO industry chain, the market status of Pharmaceutical Company (Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), Biotechnology Company (Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy CDMO.

Regionally, the report analyzes the Cell and Gene Therapy CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy CDMO industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Clinical Trial Material CDMOs, Development and Manufacturing CDMOs).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy CDMO market.

Regional Analysis: The report involves examining the Cell and Gene Therapy CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell and Gene Therapy CDMO:
Company Analysis: Report covers individual Cell and Gene Therapy CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Biotechnology Company).

Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy CDMO. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy CDMO areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell and Gene Therapy CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Clinical Trial Material CDMOs
    Development and Manufacturing CDMOs
    Other

Market segment by Application
    Pharmaceutical Company
    Biotechnology Company
    Other

Market segment by players, this report covers
    Lonza
    Charles River Laboratories
    Cytiva
    Catalent Biologics
    FUJIFILM Diosynth Biotechnologies
    BioCentriq
    RoslinCT
    Thermo Scientific
    Mesoblast
    Cellularity
    Bluebird Bio
    Editas Medicine
    Andelyn Biosciences
    Wuxi Advanced Therapies
    AGC Biologics
    Pfizer CentreOne
    Almac Group
    PCI Pharma Services

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy CDMO, with revenue, gross margin and global market share of Cell and Gene Therapy CDMO from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy CDMO.
Chapter 13, to describe Cell and Gene Therapy CDMO research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell and Gene Therapy CDMO
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell and Gene Therapy CDMO by Type
        1.3.1 Overview: Global Cell and Gene Therapy CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Cell and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
        1.3.3 Clinical Trial Material CDMOs
        1.3.4 Development and Manufacturing CDMOs
        1.3.5 Other
    1.4 Global Cell and Gene Therapy CDMO Market by Application
        1.4.1 Overview: Global Cell and Gene Therapy CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical Company
        1.4.3 Biotechnology Company
        1.4.4 Other
    1.5 Global Cell and Gene Therapy CDMO Market Size & Forecast
    1.6 Global Cell and Gene Therapy CDMO Market Size and Forecast by Region
        1.6.1 Global Cell and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Cell and Gene Therapy CDMO Market Size by Region, (2018-2029)
        1.6.3 North America Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.4 Europe Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.6 South America Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Cell and Gene Therapy CDMO Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Lonza
        2.1.1 Lonza Details
        2.1.2 Lonza Major Business
        2.1.3 Lonza Cell and Gene Therapy CDMO Product and Solutions
        2.1.4 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Lonza Recent Developments and Future Plans
    2.2 Charles River Laboratories
        2.2.1 Charles River Laboratories Details
        2.2.2 Charles River Laboratories Major Business
        2.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Product and Solutions
        2.2.4 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Charles River Laboratories Recent Developments and Future Plans
    2.3 Cytiva
        2.3.1 Cytiva Details
        2.3.2 Cytiva Major Business
        2.3.3 Cytiva Cell and Gene Therapy CDMO Product and Solutions
        2.3.4 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Cytiva Recent Developments and Future Plans
    2.4 Catalent Biologics
        2.4.1 Catalent Biologics Details
        2.4.2 Catalent Biologics Major Business
        2.4.3 Catalent Biologics Cell and Gene Therapy CDMO Product and Solutions
        2.4.4 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Catalent Biologics Recent Developments and Future Plans
    2.5 FUJIFILM Diosynth Biotechnologies
        2.5.1 FUJIFILM Diosynth Biotechnologies Details
        2.5.2 FUJIFILM Diosynth Biotechnologies Major Business
        2.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Solutions
        2.5.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
    2.6 BioCentriq
        2.6.1 BioCentriq Details
        2.6.2 BioCentriq Major Business
        2.6.3 BioCentriq Cell and Gene Therapy CDMO Product and Solutions
        2.6.4 BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 BioCentriq Recent Developments and Future Plans
    2.7 RoslinCT
        2.7.1 RoslinCT Details
        2.7.2 RoslinCT Major Business
        2.7.3 RoslinCT Cell and Gene Therapy CDMO Product and Solutions
        2.7.4 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 RoslinCT Recent Developments and Future Plans
    2.8 Thermo Scientific
        2.8.1 Thermo Scientific Details
        2.8.2 Thermo Scientific Major Business
        2.8.3 Thermo Scientific Cell and Gene Therapy CDMO Product and Solutions
        2.8.4 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Thermo Scientific Recent Developments and Future Plans
    2.9 Mesoblast
        2.9.1 Mesoblast Details
        2.9.2 Mesoblast Major Business
        2.9.3 Mesoblast Cell and Gene Therapy CDMO Product and Solutions
        2.9.4 Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Mesoblast Recent Developments and Future Plans
    2.10 Cellularity
        2.10.1 Cellularity Details
        2.10.2 Cellularity Major Business
        2.10.3 Cellularity Cell and Gene Therapy CDMO Product and Solutions
        2.10.4 Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Cellularity Recent Developments and Future Plans
    2.11 Bluebird Bio
        2.11.1 Bluebird Bio Details
        2.11.2 Bluebird Bio Major Business
        2.11.3 Bluebird Bio Cell and Gene Therapy CDMO Product and Solutions
        2.11.4 Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Bluebird Bio Recent Developments and Future Plans
    2.12 Editas Medicine
        2.12.1 Editas Medicine Details
        2.12.2 Editas Medicine Major Business
        2.12.3 Editas Medicine Cell and Gene Therapy CDMO Product and Solutions
        2.12.4 Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Editas Medicine Recent Developments and Future Plans
    2.13 Andelyn Biosciences
        2.13.1 Andelyn Biosciences Details
        2.13.2 Andelyn Biosciences Major Business
        2.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Product and Solutions
        2.13.4 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Andelyn Biosciences Recent Developments and Future Plans
    2.14 Wuxi Advanced Therapies
        2.14.1 Wuxi Advanced Therapies Details
        2.14.2 Wuxi Advanced Therapies Major Business
        2.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Solutions
        2.14.4 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Wuxi Advanced Therapies Recent Developments and Future Plans
    2.15 AGC Biologics
        2.15.1 AGC Biologics Details
        2.15.2 AGC Biologics Major Business
        2.15.3 AGC Biologics Cell and Gene Therapy CDMO Product and Solutions
        2.15.4 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 AGC Biologics Recent Developments and Future Plans
    2.16 Pfizer CentreOne
        2.16.1 Pfizer CentreOne Details
        2.16.2 Pfizer CentreOne Major Business
        2.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Product and Solutions
        2.16.4 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Pfizer CentreOne Recent Developments and Future Plans
    2.17 Almac Group
        2.17.1 Almac Group Details
        2.17.2 Almac Group Major Business
        2.17.3 Almac Group Cell and Gene Therapy CDMO Product and Solutions
        2.17.4 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Almac Group Recent Developments and Future Plans
    2.18 PCI Pharma Services
        2.18.1 PCI Pharma Services Details
        2.18.2 PCI Pharma Services Major Business
        2.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Product and Solutions
        2.18.4 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 PCI Pharma Services Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy CDMO Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Cell and Gene Therapy CDMO by Company Revenue
        3.2.2 Top 3 Cell and Gene Therapy CDMO Players Market Share in 2022
        3.2.3 Top 6 Cell and Gene Therapy CDMO Players Market Share in 2022
    3.3 Cell and Gene Therapy CDMO Market: Overall Company Footprint Analysis
        3.3.1 Cell and Gene Therapy CDMO Market: Region Footprint
        3.3.2 Cell and Gene Therapy CDMO Market: Company Product Type Footprint
        3.3.3 Cell and Gene Therapy CDMO Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy CDMO Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Cell and Gene Therapy CDMO Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2023)
    5.2 Global Cell and Gene Therapy CDMO Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    6.2 North America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    6.3 North America Cell and Gene Therapy CDMO Market Size by Country
        6.3.1 North America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        6.3.2 United States Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        6.3.3 Canada Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        6.3.4 Mexico Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    7.2 Europe Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    7.3 Europe Cell and Gene Therapy CDMO Market Size by Country
        7.3.1 Europe Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        7.3.2 Germany Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.3 France Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.5 Russia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.6 Italy Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Cell and Gene Therapy CDMO Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2018-2029)
        8.3.2 China Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.3 Japan Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.4 South Korea Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.5 India Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.7 Australia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    9.2 South America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    9.3 South America Cell and Gene Therapy CDMO Market Size by Country
        9.3.1 South America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        9.3.2 Brazil Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        9.3.3 Argentina Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        10.3.2 Turkey Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        10.3.4 UAE Cell and Gene Therapy CDMO Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Cell and Gene Therapy CDMO Market Drivers
    11.2 Cell and Gene Therapy CDMO Market Restraints
    11.3 Cell and Gene Therapy CDMO Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Cell and Gene Therapy CDMO Industry Chain
    12.2 Cell and Gene Therapy CDMO Upstream Analysis
    12.3 Cell and Gene Therapy CDMO Midstream Analysis
    12.4 Cell and Gene Therapy CDMO Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Cell and Gene Therapy CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Cell and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Lonza Company Information, Head Office, and Major Competitors
    Table 6. Lonza Major Business
    Table 7. Lonza Cell and Gene Therapy CDMO Product and Solutions
    Table 8. Lonza Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Lonza Recent Developments and Future Plans
    Table 10. Charles River Laboratories Company Information, Head Office, and Major Competitors
    Table 11. Charles River Laboratories Major Business
    Table 12. Charles River Laboratories Cell and Gene Therapy CDMO Product and Solutions
    Table 13. Charles River Laboratories Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Charles River Laboratories Recent Developments and Future Plans
    Table 15. Cytiva Company Information, Head Office, and Major Competitors
    Table 16. Cytiva Major Business
    Table 17. Cytiva Cell and Gene Therapy CDMO Product and Solutions
    Table 18. Cytiva Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Cytiva Recent Developments and Future Plans
    Table 20. Catalent Biologics Company Information, Head Office, and Major Competitors
    Table 21. Catalent Biologics Major Business
    Table 22. Catalent Biologics Cell and Gene Therapy CDMO Product and Solutions
    Table 23. Catalent Biologics Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Catalent Biologics Recent Developments and Future Plans
    Table 25. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
    Table 26. FUJIFILM Diosynth Biotechnologies Major Business
    Table 27. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Solutions
    Table 28. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
    Table 30. BioCentriq Company Information, Head Office, and Major Competitors
    Table 31. BioCentriq Major Business
    Table 32. BioCentriq Cell and Gene Therapy CDMO Product and Solutions
    Table 33. BioCentriq Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. BioCentriq Recent Developments and Future Plans
    Table 35. RoslinCT Company Information, Head Office, and Major Competitors
    Table 36. RoslinCT Major Business
    Table 37. RoslinCT Cell and Gene Therapy CDMO Product and Solutions
    Table 38. RoslinCT Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. RoslinCT Recent Developments and Future Plans
    Table 40. Thermo Scientific Company Information, Head Office, and Major Competitors
    Table 41. Thermo Scientific Major Business
    Table 42. Thermo Scientific Cell and Gene Therapy CDMO Product and Solutions
    Table 43. Thermo Scientific Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Thermo Scientific Recent Developments and Future Plans
    Table 45. Mesoblast Company Information, Head Office, and Major Competitors
    Table 46. Mesoblast Major Business
    Table 47. Mesoblast Cell and Gene Therapy CDMO Product and Solutions
    Table 48. Mesoblast Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Mesoblast Recent Developments and Future Plans
    Table 50. Cellularity Company Information, Head Office, and Major Competitors
    Table 51. Cellularity Major Business
    Table 52. Cellularity Cell and Gene Therapy CDMO Product and Solutions
    Table 53. Cellularity Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Cellularity Recent Developments and Future Plans
    Table 55. Bluebird Bio Company Information, Head Office, and Major Competitors
    Table 56. Bluebird Bio Major Business
    Table 57. Bluebird Bio Cell and Gene Therapy CDMO Product and Solutions
    Table 58. Bluebird Bio Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Bluebird Bio Recent Developments and Future Plans
    Table 60. Editas Medicine Company Information, Head Office, and Major Competitors
    Table 61. Editas Medicine Major Business
    Table 62. Editas Medicine Cell and Gene Therapy CDMO Product and Solutions
    Table 63. Editas Medicine Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Editas Medicine Recent Developments and Future Plans
    Table 65. Andelyn Biosciences Company Information, Head Office, and Major Competitors
    Table 66. Andelyn Biosciences Major Business
    Table 67. Andelyn Biosciences Cell and Gene Therapy CDMO Product and Solutions
    Table 68. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Andelyn Biosciences Recent Developments and Future Plans
    Table 70. Wuxi Advanced Therapies Company Information, Head Office, and Major Competitors
    Table 71. Wuxi Advanced Therapies Major Business
    Table 72. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Solutions
    Table 73. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Wuxi Advanced Therapies Recent Developments and Future Plans
    Table 75. AGC Biologics Company Information, Head Office, and Major Competitors
    Table 76. AGC Biologics Major Business
    Table 77. AGC Biologics Cell and Gene Therapy CDMO Product and Solutions
    Table 78. AGC Biologics Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. AGC Biologics Recent Developments and Future Plans
    Table 80. Pfizer CentreOne Company Information, Head Office, and Major Competitors
    Table 81. Pfizer CentreOne Major Business
    Table 82. Pfizer CentreOne Cell and Gene Therapy CDMO Product and Solutions
    Table 83. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Pfizer CentreOne Recent Developments and Future Plans
    Table 85. Almac Group Company Information, Head Office, and Major Competitors
    Table 86. Almac Group Major Business
    Table 87. Almac Group Cell and Gene Therapy CDMO Product and Solutions
    Table 88. Almac Group Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Almac Group Recent Developments and Future Plans
    Table 90. PCI Pharma Services Company Information, Head Office, and Major Competitors
    Table 91. PCI Pharma Services Major Business
    Table 92. PCI Pharma Services Cell and Gene Therapy CDMO Product and Solutions
    Table 93. PCI Pharma Services Cell and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. PCI Pharma Services Recent Developments and Future Plans
    Table 95. Global Cell and Gene Therapy CDMO Revenue (USD Million) by Players (2018-2023)
    Table 96. Global Cell and Gene Therapy CDMO Revenue Share by Players (2018-2023)
    Table 97. Breakdown of Cell and Gene Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 98. Market Position of Players in Cell and Gene Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 99. Head Office of Key Cell and Gene Therapy CDMO Players
    Table 100. Cell and Gene Therapy CDMO Market: Company Product Type Footprint
    Table 101. Cell and Gene Therapy CDMO Market: Company Product Application Footprint
    Table 102. Cell and Gene Therapy CDMO New Market Entrants and Barriers to Market Entry
    Table 103. Cell and Gene Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
    Table 104. Global Cell and Gene Therapy CDMO Consumption Value (USD Million) by Type (2018-2023)
    Table 105. Global Cell and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
    Table 106. Global Cell and Gene Therapy CDMO Consumption Value Forecast by Type (2024-2029)
    Table 107. Global Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023)
    Table 108. Global Cell and Gene Therapy CDMO Consumption Value Forecast by Application (2024-2029)
    Table 109. North America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 110. North America Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 111. North America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. North America Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. North America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 114. North America Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 115. Europe Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 116. Europe Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 117. Europe Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 118. Europe Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 119. Europe Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 122. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 123. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 124. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 125. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 126. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 127. South America Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 128. South America Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 129. South America Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 130. South America Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 131. South America Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 132. South America Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 133. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 135. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 136. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 138. Middle East & Africa Cell and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 139. Cell and Gene Therapy CDMO Raw Material
    Table 140. Key Suppliers of Cell and Gene Therapy CDMO Raw Materials
List of Figures
    Figure 1. Cell and Gene Therapy CDMO Picture
    Figure 2. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
    Figure 4. Clinical Trial Material CDMOs
    Figure 5. Development and Manufacturing CDMOs
    Figure 6. Other
    Figure 7. Global Cell and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Cell and Gene Therapy CDMO Consumption Value Market Share by Application in 2022
    Figure 9. Pharmaceutical Company Picture
    Figure 10. Biotechnology Company Picture
    Figure 11. Other Picture
    Figure 12. Global Cell and Gene Therapy CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Cell and Gene Therapy CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Cell and Gene Therapy CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Cell and Gene Therapy CDMO Consumption Value Market Share by Region in 2022
    Figure 17. North America Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Cell and Gene Therapy CDMO Revenue Share by Players in 2022
    Figure 23. Cell and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Cell and Gene Therapy CDMO Market Share in 2022
    Figure 25. Global Top 6 Players Cell and Gene Therapy CDMO Market Share in 2022
    Figure 26. Global Cell and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
    Figure 27. Global Cell and Gene Therapy CDMO Market Share Forecast by Type (2024-2029)
    Figure 28. Global Cell and Gene Therapy CDMO Consumption Value Share by Application (2018-2023)
    Figure 29. Global Cell and Gene Therapy CDMO Market Share Forecast by Application (2024-2029)
    Figure 30. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Cell and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 64. Cell and Gene Therapy CDMO Market Drivers
    Figure 65. Cell and Gene Therapy CDMO Market Restraints
    Figure 66. Cell and Gene Therapy CDMO Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Cell and Gene Therapy CDMO in 2022
    Figure 69. Manufacturing Process Analysis of Cell and Gene Therapy CDMO
    Figure 70. Cell and Gene Therapy CDMO Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonza
Charles River Laboratories
Cytiva
Catalent Biologics
FUJIFILM Diosynth Biotechnologies
BioCentriq
RoslinCT
Thermo Scientific
Mesoblast
Cellularity
Bluebird Bio
Editas Medicine
Andelyn Biosciences
Wuxi Advanced Therapies
AGC Biologics
Pfizer CentreOne
Almac Group
PCI Pharma Services

Related Reports

Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029

Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029

date 21 Sep 2023

date Medical Care

The global Cell and Gene Therapy CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Cell and Gene Therapy CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Cell and Gene Therapy CDMO market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2024-2030

Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2024-2030

date 04 Mar 2024

date Medical Care

The global Cell and Gene Therapy CDMO market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Cell and Gene Therapy CDMO

Cell and Gene Therapy CDMO Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>